Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma

Clinical Trial ID NCT00768157

Rank	Title	Journal	Year	PubWeight™‹?›
1	A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization.	Hepatology	2006	2.05
2	Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma.	J Hepatol	2007	1.86
3	Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma.	J Hepatol	2004	1.82
4	The impact of hepatitis B viral load on recurrence after complete necrosis in patients with hepatocellular carcinoma who receive transarterial chemolipiodolization: implications for viral suppression to reduce the risk of cancer recurrence.	Cancer	2007	0.93
5	Reactivation of viral replication after liver resection in patients infected with hepatitis B virus.	Ann Surg	2001	0.89
6	Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B.	World J Surg	2002	0.80
7	Significance of viral status on prognosis after resection of hepatitis B virus related hepatocellular carcinoma.	J Hepatol	2007	0.75